| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |